<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04609917</url>
  </required_header>
  <id_info>
    <org_study_id>KY20201021-2</org_study_id>
    <nct_id>NCT04609917</nct_id>
  </id_info>
  <brief_title>Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation</brief_title>
  <official_title>Proposal of Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Force Military Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Force Military Medical University, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the most technically&#xD;
      challenging procedures in gastrointestinal endoscopy. Selective deep cannulation is a&#xD;
      critical step for the performance of ERCP. The incidence of difficult cannulation has been&#xD;
      reported in many studies, ranging from 10% to 40% in patients with native papilla. Difficult&#xD;
      cannulation is an independent risk factor for post-ERCP pancreatitis (PEP).&#xD;
&#xD;
      The definition of difficult cannulation has been proposed by European Society of&#xD;
      Gastrointestinal Endoscopy (ESGE) guidelines. Initial cannulation is considered difficult&#xD;
      with the presence of one or more of the following: more than 5 min for attempting to&#xD;
      cannulate; more than 5 contacts with the papilla; more than 1 unintended pancreatic duct&#xD;
      cannulation or opacification. The clear definition of difficult cannulation is important for&#xD;
      making decisions during or after ERCP, including determining the appropriate time to transfer&#xD;
      to advanced cannulation techniques (e.g. early precut) and whether prophylactic methods&#xD;
      should be administrated to reduce the risk of PEP. Although 5-5-1 criteria have been widely&#xD;
      used during ERCP practice or in relevant studies, it remains unclear whether the current&#xD;
      criteria are suitable for the cannulation procedure with trainee involvement. Because of&#xD;
      inexperienced manipulation of the scope and accessories, the involvement of trainees&#xD;
      generally increases the overall cannulation time and attempts, which are the two important&#xD;
      parameters in the criteria of difficult cannulation. Thus, the investigators hypothesized&#xD;
      that the definition of difficult cannulation in trainee-involved cannulation might be&#xD;
      different from the traditional 5-5-1 criteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">October 20, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rates of difficult cannulation</measure>
    <time_frame>2 hours</time_frame>
    <description>The proportion of the participants with cannulation-related parameters (cannulation time, cannulation attempts, or inadvertent PD cannulation) above the 75% percentile</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidences of PEP</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall adverse events</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the proportion of advanced cannulation methods</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">4415</enrollment>
  <condition>Biliary Cannulation</condition>
  <condition>Endoscopic Retrograde Cholangiopancreatography</condition>
  <arm_group>
    <arm_group_label>trainee group</arm_group_label>
    <description>Patients with native papilla who underwent selective biliary cannulation with trainee involvement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-trainee group</arm_group_label>
    <description>Patients with native papilla who underwent selective biliary cannulation without trainee involvement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trainee invlovement</intervention_name>
    <description>Patients underwent selective biliary cannulation with trainee involvement</description>
    <arm_group_label>trainee group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with native papilla who underwent ERCP in Xijing Hospital in China&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with native papilla&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  indications of major or minor pancreatic duct (PD) cannulation; no attempts of&#xD;
             cannulation due to inaccessible papilla; cannulation via the papillary fistula;&#xD;
             patients with duodenal stenosis or anatomical deformity secondary to prior surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Endoscopic center, Xijing Hospital of Digestive Diseases</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, van Hooft JE. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Feb;52(2):127-149. doi: 10.1055/a-1075-4080. Epub 2019 Dec 20.</citation>
    <PMID>31863440</PMID>
  </reference>
  <reference>
    <citation>Ismail S, Udd M, Lindström O, Rainio M, Halttunen J, Kylänpää L. Criteria for difficult biliary cannulation: start to count. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1200-1205. doi: 10.1097/MEG.0000000000001515.</citation>
    <PMID>31464778</PMID>
  </reference>
  <reference>
    <citation>Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, Kleveland PM, Nordblad Schmidt P, Saarela A, Swahn F, Toth E, Mustonen H, Löhr JM. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014 Jun;49(6):752-8. doi: 10.3109/00365521.2014.894120. Epub 2014 Mar 14.</citation>
    <PMID>24628493</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Air Force Military Medical University, China</investigator_affiliation>
    <investigator_full_name>Yanglin Pan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>Difficult cannulation</keyword>
  <keyword>Trainee</keyword>
  <keyword>PEP</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

